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Throughout history, women have faced unique health concerns, yet their physical,
medical and psychological needs were not thought to differ from men's ... until recent-
ly. Over the last decade, the topic ofwomen's health has captured the attention ofdoctors,
researchers and politicians as well as millions of women around the world. However, the
acceptance of women's health as a field meriting serious research efforts did not come
quickly or easily. The three women featured in this article, Dr. Bernadine Healy, Dr. Ruth
Kirschstein and Dr. Florence Haseltine, all played pivotal roles in focusing attention on
the inadequacy ofwomen's health care and helped to establish women's health promotion
as an issue of national importance. Intended not as a scientific review but rather as a
descriptive biographical piece, this paper describes the contributions of three women to
the field ofwomen's health.
DR. BERNADINE HEALY
As the leader of many prominent institutions, which have included the National
Institutes ofHealth (NIH), the Research Institute ofThe Cleveland Clinic Foundation, and
currently the Ohio State University College ofMedicine, Dr. Bernadine Healy has worked
to call attention to women's health. Dr. Healy believes thepublic is now receiving the mes-
sage: health issues affecting women need to be taken seriously. "Women's health has real-
ly become apriority nationally," she says [1]. "There's been atotal headshift in awareness,
an awakening that has touched all aspects of women's health research and practice" [1].
As an individual who has greatly contributed to the emergence of women's health as a
valid area ofresearch through her leadership roles, Dr. Healy feels inspired by the excite-
ment she senses when she addresses women about their health. "When I speak to groups
of women about these issues, there's always an electricity and energy in the room," she
says [1]. "And this happens across all walks of life, old and young, women of various
political and religious ideologies, those with fancy educations and without, rich and poor
... it captures the interest ofall women" [1].
Attempting to channel some of this enthusiasm, Dr. Healy launched the Women's
Health Initiative (WHI)b during her term as the Director of the National Institutes of
Health. The WHI, a $628 million study that will include 150,000 women over 14 years,
ranks as the largest and most expensive effort ever to focus on the health of women. Not
only do WHI researchers expect to gain a better understanding of the causes, prevention
and treatment of the three most prevalent diseases that affect women, heart disease, can-
cer and osteoporosis, the massive effort has also helped to affirm the importance of
women-focused biomedical studies. "I'm glad to have been at NIH at the time I was able
to have made an impact with the Women's Health Initiative," Dr. Healy reflects [1]. "I
aTo whom all correspondence should be sent: Sarah Nagae, 36004 3rd Avenue South, Federal Way,
WA, 98003. Tel: 206-838-5968.
bAbbreviations: WHI, Women's Health Initiative; STD, sexually transmitted disease; PHS, Public
Health Service; NIGMS, National Institute ofGeneral Medical Science; ORWH, Office ofResearch
on Women's Health.
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think the Women's Health Initiative has institutionalized women's health among major
academic centers. There will now be interest and focus beyond my time. That way, if
you're hit by the proverbial milk truck or are the victim of an election, it's nice to know
that what you worked for will continue" [1].
In addition to beginning the WHI, Dr. Healy also established the Shannon Awards,
grants designed to foster creative, innovative approaches to biomedical research. Through
these projects, Dr. Healy helped generate unprecedented interest and investment in
women's health at the federal level. She also led the way for women in health research
administration by serving as the Chairman of the Research Institute of The Cleveland
Clinic Foundation and as the Deputy Director of the Office of Science and Technology
Policy at the White House. A trained cardiologist, Dr. Healy served one term as President
of the American Heart Association, during which she focused on women's health issues
by initiating a Women and Minorities Leadership Task Force as well as a Women and
Heart Disease Program that branched out to centers across the country. She is the current
Editor-in-Chief ofthe Journal ofWomen's Health and has received, among her many hon-
ors, the Charles A. Dana Foundation Award for exceptional leadership in the strategic
direction of NIH, the 1992 Glamour "Woman of the Year Award," as well as the Golden
HeartAward ofthe American HeartAssociation. Proving a successful leader ofboth gov-
ernment and private research institutions, Dr. Healy recently took on the new challenge of
leading an academic institution when she left her position as Director of the Section of
Health and Science Policy at the Cleveland Clinic Foundation's Page Center last fall to
become the Dean of the Ohio State University College ofMedicine.
Although most of Dr. Healy's efforts have been geared towards administration, her
dedication to enhancing women's knowledge of how they can improve their own health
remains firm. "I do believe that education is power," she says [1]. "There have been times
when I've talked to women who are not able to explain what happened to them at the doc-
tor's office. It's a big issue for women, they have to become assertive in finding out about
their health and getting the framework of knowledge they need" [1]. In her recently pub-
lished book, "A New Prescription for Women's Health" [2], Dr. Healy identifies 10 areas
as critical to the well-being of women during all stages of life and in which she believes
further research is needed. They include nutrition, reproductive life, sexually transmitted
diseases (STDs), menopause, cancer, depression and anxiety, heart disease, stroke, osteo-
porosis and Alzheimer's disease. "I don't single out any one because women have to be
aware of them in totality," she says [1]. "These issues are important across the lifespan.
Women need to take a lifelong interest in them" [1]. Using the example of STDs, Dr.
Healy points out that many women are aware ofthe highly-publicized AIDS-causing HIV
virus, yet they lack information on more common infections such as HPV (Human
PapillomaVirus) and chlamydia. Women not only need a more complete understanding of
such diseases, she believes, but also need to know what personal risk factors make them
vulnerable to these conditions.
Dr. Healy is convinced that Americans, particularly women, are fundamentally inter-
ested in learning about health issues, however, she would like to see more women take the
initiative in educating themselves. As evidence ofthis interest, she cites the number ofpeo-
ple who choose to exercise and read health-related literature. "I think health care is a pri-
ority in this country and that people have high expectations about their health. There's an
inherent desire to become in command of one's own health, a cultural phenomena to take
charge healthwise" [1]. Dr. Healy's enthusiasm extends to the women's health research
community which she believes is more adequately responding to women's needs than in the
past, yet she describes herselfas a "cautious optimist" in regard to research. "The proof will
be in the product. There have been more resources directed into areas that disproportion-
ately or exclusively help women such as new osteoporosis drugs and hormone therapies,
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but in reality, there's still a knowledge gap that can't be closed overnight" [1]. Bridging this
gap, formed during years of inadequate attention to, and funding for, the health needs of
women, is contingent on today's investments in research, Dr. Healy believes. "The outcome
will depend on the scientists, physicians and others who direct their intellect, capabilities
and creativity to issues that relate to women" [1]. Dr. Healy ranks as a prominent institu-
tional leader whose devoted effort at focusing the spotlight on women's health has helped
secure health improvements for American women.
DR. RUTH KIRSCHSTEIN
During her 37 years as a Public Health Service (PHS) administrator, Dr. Ruth
Kirschstein has developed a uniquely comprehensive view of the evolution of women's
health research and the impact of biomedical findings on the lives of women. From her
perspective as the Deputy Director at NIH, she views education and empowerment as the
tools that arm women in their quests to be and stay healthy. The challenge, according to
Dr. Kirschstein, lies in convincing women to take apro-active roles in theirhealth care and
assert their right to be fully informed. "Women have to take responsibility about their own
health. They have to learn, ask questions and insist that their doctors and health care
providers explain the situation to them in terms they can understand" [3]. Dr. Kirschstein
envisions women exercising greater control over their health by expanding their knowl-
edge of research findings through enhanced public education. "Women need to be
informed of the various issues on their own so they don't let their health care provider
make their decisions for them," she says [3]. "They can't be afraid to ask for a second
opinion either" [3].
Dr. Kirschstein characterizes her personal promotion of women's health as a contin-
uum spanning 15 years. During this time, the trained pathologist has acted as amajorforce
in the transformation of women's health promotion from a non-existent issue to one that
has captured the attention and gained the respect ofthe medical community. According to
Dr. Kirschstein, the realization and understanding among researchers that women have
special health concerns that merit acknowledgment and further study ranks as a pivotal
development in women's health. "People now realize that conclusions can't be drawn that
say women and men will necessarily respond similarly to therapeutic interventions or
diagnostic tests. It's now accepted that we need to actually include women in these trials
for new drugs or therapies" [3].
During her early career, Dr. Kirschstein's research accomplishments included the
development, refinement and application of a test for assuring the safety of viral vaccines
such as the polio, measles and rubella vaccines. Emerging as one ofthe first women lead-
ers at NIH, she played a pivotal role in advancing the institutionalization of women's
health within the NIH structure. In both hercurrentposition, which she has held since July
1993, and formerly as Director of the National Institute of General Medical Sciences
(NIGMS), Dr. Kirschstein has firmly supported women-focused research. She demon-
strates her dedication not only to women's health but the nation's health overall as the co-
chair of the Department of Health and Human Services Secretary's Special Emphasis
OversightCommittee on Science andTechnology. She also received the Presidential Rank
Award for Distinguished Executives, the highest honor awarded to a career civil servant.
While serving as NIGMS director in 1983, Dr. Kirschstein began her formal work in
women's health. She chaired the PHS Task Force for Women's Health Issues in 1983 and
1984 which released the "first real, comprehensive report on women's health," in 1985. In
order to fully investigate the status of women's health, the Task Force held public meet-
ings across the country focusing on the diversity of women's health needs and the social
influences which affect women's health. Dr. Kirschstein guided the Task Force in defin-
ing the term "women's health issues" as diseases or conditions that are unique to women,
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are more prevalent or more serious in women, or for which specific risk factors or inter-
ventions differ for women. The Task Force's recommendation that the PHS expand bio-
medical and behavioral research on women's health resulted in the establishment of
women's health advisory committees in each PHS agency.
The Task Force has since evolved into the Coordinating Committee on Women's
Health Issues which Dr. Kirschstein chaired from 1985-1990 and has co-chaired since.
Largely as a result ofthe recommendations ofDr. Kirschstein and others, NIH opened an
Office ofResearch onWomen's Health (ORWH) in 1991 afterthe passage oftheWomen's
HealthEquity Act. As itsActing Director, Dr. Kirschstein laid the foundation forthe office
and established its organizational structure. She defined the office's focus by insisting that
the word "research" be placed in the middle ofthe title, fearing that the word could easi-
ly be dropped if placed at the end. Inspired by the achievements of the ORWH over the
past five years, Dr. Kirschstein feels issues of women's health are finally receiving the
attention they deserve. "I do think we've come a long way. There's a lot ofexcitement in
the field right now" [3]. She points to new studies focusing on areas such as osteoporosis,
heart disease in post-menopausal women and breast cancer as evidence that these once
overlooked conditions are now considered legitimate areas of research in which more
appropriate treatments and drug therapies are being developed. Dr. Kirschstein also sees
this enthusiasm in the search for the genes thought to increase a woman's risk of heredi-
tary breast cancer, a discovery she considers ofprime importance.
Dr. Kirschstein's accomplishments as a pathologist and as a female leader at NIH
helped show the way for women in a traditionally male-dominated field. However, she
remains concerned that women are not as successful in the academic research establish-
ment that they should be. "While I see things on the research front getting better, I'm not
sure thatenough women are interested in going into biomedical and research careers," she
says [3]. "We need women in medical school faculty positions, represented at the levels
ofdeans, vice presidents, and chairs ofdepartments. When women are there, they're often
in lower level positions" [3]. In her experience, women researchers tend to focus on dis-
eases whichprimarily affect women. The way to ensure thatwomen's health issues are not
overlooked is by making sure women are represented in decision-making positions.
Dedicating her career to advancing the scope ofmedical knowledge, Dr. Kirschstein
worries that funding cuts could undermine the advances in public heath education that she
views as crucial to improving the quality ofhealth care. "I'm concerned that we won't be
able to provide adequate health education and science education in general that school-age
children lack. We're in danger oflosing the basic understanding that people have gained"
[3]. While how well tomorrow's medical advances will be understood by the public
remains uncertain, clearly Dr. Kirschstein's pioneering efforts in the field of women's
health research have played amajor role in elevating that level ofcomprehension to where
it is today.
DR. FLORENCE HASELTINE
Completing this trio ofleaders in the area ofwomen's health, Dr. Florence Haseltine's
voice and influence have helped push the issue of women's health into the political spot-
light. Due in no small part to Dr. Haseltine's efforts, legislators and the public have grown
to regard women's health as a valid area of clinical practice and research. Sharing her
enduring interest in the status of women's health research with political leaders, members
of women's activist groups, and journalists, Dr. Haseltine has worked to point out the
inequities in biomedical research funding and convince these groups that disparities
should be remedied.
Because women's bodies had for so long been viewed primarily on the basis of their
reproductive capacities, those advocating forsupportofstudies focusing on non-reproductive
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related conditions decided to downplay this aspect ofwomen's health. Dr. Haseltine, howev-
er, believes that it is now time to re-emphasize what makes women unique. "Due to politics,
wehad totake thereproductive tractout, now we have toputitbackin. Since women are now
considered as complete individuals, we need to view the reproductive tract as another part of
the body that needs to be taken care of' [4]. While research has, in the past, tended to stray
from probing into gender-based differences, Dr. Haseltine believes that because the repro-
ductive tract directly influences so many other systems, it should be the central focus ofnew
research. "We need to go back to the basics - men and women arejust going to be differ-
ent," she says [4]. "Research needs to take advantage ofthesedifferences to see whathappens
in all kinds ofsituations. As far as basic science goes, I'm interested in the reproductive tract
model being used more than it is. There's not a single process that doesn't affect it" [4].
In her position as Director of the Center for Population Research in the National
Institute of Child Health and Human Development at NIH, Dr. Haseltine promotes this
integrated picture of women's health: that reproduction plays a central but not singular
role. As head of the center, Dr. Haseltine administers funding of research and research
training in the reproductive sciences, including the development of contraceptives, the
evaluation ofcontraceptive and reproductive products and procedures, and demographics
and behavioral science research related to population issues. She has been instrumental in
starting the Reproductive Scientists Development Program which places young obstetri-
cian-gynecologists in basic science laboratories. Through the program, she promotes basic
research in the area of reproductive biology and also serves as a mentor to physicians
beginning their research careers.
As an obstetrician-gynecologist, an expert in reproductive endocrinology and human
genetics and an administrator, Dr. Haseltine has witnessed a major shift in how individu-
als within the research community respond to studies focusing on women. "Women's
health went from something that would notbe taken seriously ifit was proposed for study,
to a topic thatmight puzzle an advisor but that wouldn't be considered inappropriate" [4].
Since research administrators have come to regard the study of conditions affecting
women as a priority, Dr. Haseltine has been impressed, although not surprised by the
response. "When challenged by funding possibilities, academic institutions have had the
interest, the staff and the capability to develop programs in women's health research. The
pharmaceutical industry has likewise responded by establishing women's health units,
some with research components and some without," she wrote in the Journal ofWomen's
Health [5], of which she is the Senior Editor.
Throughout her career Dr. Haseltine has demonstrated a strong commitment to
women's health and has devoted her energy to convincing her colleagues of the impor-
tance of this study. In addition to working within NIH by involving the Center for
Population Research in women-in-health programs and initiatives, she has also served on
committees which address the Status ofWomen at both Harvard andYale Universities and
was a member oftheYale Committee on the Education ofWomen. Among her other pro-
fessional positions, Dr. Haseltine serves as the President of the Women's Council of the
American Fertility Society, as an advisory panel member of the American Medical
Association's Women's Health Campaign and as an Honorary Fellow of the American
College ofObstetricians andGynecologists. Her numerous publications include articles in
the areas ofreproductive endocrinology, the role ofwomen in the medical profession, and
the status of women's health in health care reform.
Recognizing the need to convince lawmakers and the public of the necessity of
women's health research, Dr. Haseltine co-founded the Society for the Advancement of
Women's Health Research in 1990 and currently serves as its president. In this role, she
works to eliminate the obstacles which hinder research on women's health such as lack of
financial support, exclusion of women in clinical trials, and the dearth of women leaders
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in health professions. "The Society was started in 1989 to promote the field of gynecolo-
gy at NIH," she explains [4]. "Part of that effort required documenting the number of
women in clinical trials. The General Accounting Office was requested to examine how
many women were in clinical trials at NIH. Shortly after that the Society was officially
chartered [4]." Through the Society, Dr. Haseltine carries on the struggle for research sup-
port and public attention for women's health research. One instance that convinced Dr.
Haseltine of the impact of research and health-education efforts came about when her
eighth-grade daughter asked her ifshe knew what the number one killer ofwomen is. Her
daughter then "informed" her that it was heart disease and not breast cancer. "Young peo-
ple think and ask questions about women's health now," Dr. Haseltine said [4]. "That's a
major accomplishment" [4].
CONCLUSIONS
As physicians, researchers, administrators and women, these three accomplished
individuals identified the need for more research devoted to women's health issues and
better overall health care for women. Responding to that need, each woman forged a path
in women's health, Dr. Healy with ground-breaking contributions as an institutional
leader, Dr. Kirschstein with accomplishments as a director at NIH and Dr. Haseltine with
promotion of women's health to the public. In calling attention to the long-overlooked
medical problems which women deal with each day, all three of these physicians are
responsible for shaping the face of women's health as it looks today. The results of their
energies have improved the lives of women and men, and will continue to do so for years
to come.
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